Eleven Therapeutics Raises $22m Series Seed

In the News

2/8/2022

London, UK

Round includes $9 Million from the Bill & Melinda Gates Foundation, aimed at ushering in the next generation of RNAi therapeutics

https://medium.com/@eleventx/eleven-therapeutics-announces-22-million-in-seed-funding-7a51cbc1bce7

Related Resources

Guidde: The AI-native horizontal PLG startup that could

From Chrome Extension to Enterprise Platform: Guidde’s Masterclass in Product-Led Growth

The SaaS Reckoning: Surviving the AI Token Revolution

Public SaaS faces a structural reckoning as valuations plunge while the market demands autonomous execution. To survive this "Fork in the Road," incumbents must evolve from mere Systems of Record into Systems of Context. By moving beyond organizing work to actually completing it, software can finally bridge the AI value gap.

Zocks, raises $45m Series B to Expand its Agentic AI for Financial Advisors

Congrats to portfolio company Zocks on its $45m Series B. Trusted by thousands of advisors and firms of every size, Zocks has unique product market fit with its AI solution that saves financial advisors tens of hours each month.